期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 109, 期 25, 页码 10001-10005出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1207911109
关键词
metabolism; thermogenesis; respiratory quotient; norepinephrine; white adipose tissue
资金
- National Institutes of Health (NIH) [DK087317, DK055545, DK033201, DK081604, DK046200, RR025757]
- National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK036836]
- Clinical Translational Science Award [UL1RR025758]
- BIDMC from the National Center for Research Resources
- Harvard Catalyst/The Harvard Clinical and Translational Science Center (NIH [UL1 RR 025758]
- Harvard University
- Eli Lilly Foundation
As potential activators of brown adipose tissue (BAT), mild cold exposure and sympathomimetic drugs have been considered as treatments for obesity and diabetes, but whether they activate the same pathways is unknown. In 10 healthy human volunteers, we found that the sympathomimetic ephedrine raised blood pressure, heart rate, and energy expenditure, and increased multiple circulating metabolites, including glucose, insulin, and thyroid hormones. Cold exposure also increased blood pressure and energy expenditure, but decreased heart rate and had little effect on metabolites. Importantly, cold increased BAT activity as measured by F-18-fluorodeoxyglucose PET-CT in every volunteer, whereas ephedrine failed to stimulate BAT. Thus, at doses leading to broad activation of the sympathetic nervous system, ephedrine does not stimulate BAT in humans. In contrast, mild cold exposure stimulates BAT energy expenditure with fewer other systemic effects, suggesting that cold activates specific sympathetic pathways. Agents that mimic cold activation of BAT could provide a promising approach to treating obesity while minimizing systemic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据